Deciphera Pharmaceuticals, LLC
- Active openings
- 20+
- US-based roles
- 20+
- Remote-friendly
- 20+
- Last updated
- 2026-09-11
What Deciphera Pharmaceuticals, LLC is hiring for
Open positions
20+ active- Senior Specialist, Compound ManagementLawrence, KSSep 11
- Senior Specialist, Compound ManagementWaltham, MASep 9
- Scientist III, Biological ScienceLawrence, KSSep 5
- Medical Science Liaison II, Great PlainsDenver, COAug 27
- Director, Intellectual PropertyWaltham, MAAug 27
About Deciphera Pharmaceuticals, LLC
Claim to unlockMission, culture, and benefits - visible once this page is claimed and verified.
Updates
Deciphera Pharmaceuticals Announces First Patient Dosed in Pivotal Phase 3 INTREPID Study of Sapablursen in Polycythemia Vera
Ono Pharma Submits an Application for Approval of Ripretinib (DCC-2618) in Patients with Advanced Gastrointestinal Stromal Tumor in Japan
Deciphera Pharmaceuticals Announces U.S. Food and Drug Administration Acceptance for Filing of New Drug Application for Tirabrutinib in Patients with Relapsed or Refractory PCNSL
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting
Deciphera Announces Multiple Data Presentations at the Connective Tissue Oncology Society (CTOS) Annual Meeting 2025
Deciphera Presents 2-Year Efficacy and Safety Results from MOTION Phase 3 Study of ROMVIMZA™ (vimseltinib) in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the European Society for Medical Oncology Congress 2025